Long-term Study of Lemborexant in Insomnia Disorder (SUNRISE 2)

NCT02952820 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

971

Enrollment

INDUSTRY

Sponsor class

Conditions

Insomnia Disorder

Interventions

DRUG: lemborexant
DRUG: Placebo

Sponsor

Eisai Inc.